Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05904496 |
Title | A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | BeiGene |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ESP | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Md Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Next Oncology | San Antonio | Texas | 78229 | United States | Details | |
Monash Health | Clayton | Victoria | 3168 | Australia | Details | |
Peter Maccallum Cancer Centre | Melbourne | Victoria | 3000 | Australia | Details | |
Linear Clinical Research | Nedlands | Western Australia | 6009 | Australia | Details | |
Hospital Universitario Vall Dhebron | Barcelona | 08035 | Spain | Details | ||
Start Madrid Fundacion Jimenez Diaz | Madrid | 28040 | Spain | Details |